The NHS Long Term Plan (LTP) sets out ambitious aims for improving cancer care in the UK. This includes diagnosing 75% of cancers at stages 1 and 2 and helping an additional 55,000 people each year survive for five years or more following cancer diagnosis.
With a focus on these targets, the Wessex Cancer Alliance (WCA) and Health Innovation Wessex (formerly Wessex AHSN) are working together to identify innovations to adopt and spread to enable teams across Wessex to achieve this ambition.
The primary need of the programme is to spread the adoption of innovations that have been tested and proven to increase the numbers of cancers diagnosed at an early stage. This will include innovations identified by the national cancer innovation group and those identified by the WCA/Health Innovation Wessex team that address local, unmet needs.
The Wessex early cancer diagnosis innovation programme is keen to hear about and share how any innovations that are currently in use across Wessex to improve and support any part of cancer care pathways. We want to learn from you, please complete our Wessex Cancer Innovation Case Study Form.
NIHR Evidence publishes new Collection on early detection of cancer
A new collection of evidence released by the National Institute for Health Research (NIHR) d...